Stephen J. Carriere - 19 Jan 2023 Form 4 Insider Report for Evelo Biosciences, Inc.

Role: Principal Accounting Officer
Signature: /s/ Stephen J. Carriere
Issuer symbol: EVLO on OTC
Transactions as of: 19 Jan 2023
Net transactions value: -$160
Form type: 4
Filing time: 23 Jan 2023, 16:35:06 UTC
Previous filing: 21 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVLO	Common Stock	Options Exercise		+354			354	19 Jan 2023	Direct	F1, F2
transaction	EVLO	Common Stock	Sale	$160	-151	-43%	$1.06	203	23 Jan 2023	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVLO	Restricted Stock Units	Options Exercise	$0	-354	-25%	$0.000000	1,063	19 Jan 2023	Common Stock	354	$0.000000	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Settlement of shares of Common Stock acquired upon the vesting of Restricted Stock Units previously granted to the reporting person.
F2	The price is N/A.
F3	The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.06 to $1.0712, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
F5	The Restricted Stock Units vest in four substantially equal annual installments at the end of each annual anniversary of the date of grant, subject to continued employment on such dates.